Early study drug for advanced solid tumors in adults
Part of Cancer clinical trials.
This Phase 1 trial tests a new experimental medicine (FZ-AD004) in adults with advanced solid tumors. It aims to see how the drug behaves in the body and whether it’s safe enough to continue in patients with measurable cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to sign a consent form to join the study
- You must be between 18 and 75 years old, and able to join the study
- Your cancer must be an advanced “solid tumor,” confirmed by biopsy or cell test
- You must have visible/measurable tumors on scans (measurable lesions)
- You should be expected to live at least 12 weeks and be active enough (ECOG 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests XZB-0004 in adults with solid cancers to check safety and how the body responds to the drug. It may help doctors learn whether this treatment could be useful for certain tumor types, including non-small cell lung cancer.
This trial tests an experimental drug called FXB0871 in people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug is safe and effective, and patients who enroll will receive close monitoring throughout the study.
This trial tests a new drug called FG-B901, either alone or with chemotherapy, for people with advanced solid tumors that haven't responded to standard treatment. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called FZ-AD005 for people with advanced solid tumors, especially small cell lung cancer (SCLC) or large cell neuroendocrine carcinoma (LCNEC). It may help if standard treatments are no longer working.
This trial tests a new drug called ZE94-0605 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if it is safe and can shrink tumors.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
Hear when a new Advanced and Metastatic Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.